<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-02-05" modified="2020-10-07" version="131">
<accession>Q14207</accession>
<accession>A8K1V5</accession>
<accession>A8K6M2</accession>
<accession>Q13632</accession>
<accession>Q14967</accession>
<accession>Q16580</accession>
<accession>Q86W55</accession>
<accession>Q8IWE9</accession>
<name>NPAT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein NPAT</fullName>
</recommendedName>
<alternativeName>
<fullName>Nuclear protein of the ataxia telangiectasia mutated locus</fullName>
<shortName>Nuclear protein of the ATM locus</shortName>
</alternativeName>
<alternativeName>
<fullName>p220</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NPAT</name>
<name type="synonym">CAND3</name>
<name type="synonym">E14</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genome Res." volume="6" first="439" last="447">
<title>Identification and characterization of a new gene physically linked to the ATM gene.</title>
<authorList>
<person name="Imai T."/>
<person name="Yamauchi M."/>
<person name="Seki N."/>
<person name="Sugawara T."/>
<person name="Saito T."/>
<person name="Matsuda Y."/>
<person name="Ito H."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Hori T."/>
</authorList>
<dbReference type="PubMed" id="8743993"/>
<dbReference type="DOI" id="10.1101/gr.6.5.439"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ILE-575</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="1785" last="1791">
<title>A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies.</title>
<authorList>
<person name="Byrd P.J."/>
<person name="Cooper P.R."/>
<person name="Stankovic T."/>
<person name="Kullar H.S."/>
<person name="Watts G.D.J."/>
<person name="Robinson P.J."/>
<person name="Taylor A.M.R."/>
</authorList>
<dbReference type="PubMed" id="8923007"/>
<dbReference type="DOI" id="10.1093/hmg/5.11.1785"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS LEU-295; MET-399; ILE-575; ILE-621; GLU-967; VAL-973; ALA-987 AND ARG-1191</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Genomics" volume="42" first="388" last="392">
<title>The structure and organization of the human NPAT gene.</title>
<authorList>
<person name="Imai T."/>
<person name="Sugawara T."/>
<person name="Nishiyama A."/>
<person name="Shimada R."/>
<person name="Ohki R."/>
<person name="Seki N."/>
<person name="Sagara M."/>
<person name="Ito H."/>
<person name="Yamauchi M."/>
<person name="Hori T."/>
</authorList>
<dbReference type="PubMed" id="9205109"/>
<dbReference type="DOI" id="10.1006/geno.1997.4769"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ILE-575</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS PHE-540; ILE-575 AND LYS-999</scope>
<source>
<tissue>Hippocampus</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1369</scope>
<scope>VARIANT ILE-575</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Mamm. Genome" volume="8" first="129" last="133">
<title>CAND3: a ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1.</title>
<authorList>
<person name="Chen X."/>
<person name="Yang L."/>
<person name="Udar N."/>
<person name="Liang T."/>
<person name="Uhrhammer N."/>
<person name="Xu S."/>
<person name="Bay J.-O."/>
<person name="Wang Z."/>
<person name="Dandakar S."/>
<person name="Chiplunkar S."/>
<person name="Klisak I."/>
<person name="Telatar M."/>
<person name="Yang H."/>
<person name="Concannon P."/>
<person name="Gatti R.A."/>
</authorList>
<dbReference type="PubMed" id="9060412"/>
<dbReference type="DOI" id="10.1007/s003359900371"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-1169</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="456" last="461">
<title>Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.</title>
<authorList>
<person name="Zhao J."/>
<person name="Dynlacht B."/>
<person name="Imai T."/>
<person name="Hori T."/>
<person name="Harlow E."/>
</authorList>
<dbReference type="PubMed" id="9472014"/>
<dbReference type="DOI" id="10.1101/gad.12.4.456"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCNE1 AND CDK2</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="2283" last="2297">
<title>NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.</title>
<authorList>
<person name="Zhao J."/>
<person name="Kennedy B.K."/>
<person name="Lawrence B.D."/>
<person name="Barbie D.A."/>
<person name="Matera A.G."/>
<person name="Fletcher J.A."/>
<person name="Harlow E."/>
</authorList>
<dbReference type="PubMed" id="10995386"/>
<dbReference type="DOI" id="10.1101/gad.827700"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="2298" last="2313">
<title>Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.</title>
<authorList>
<person name="Ma T."/>
<person name="Van Tine B.A."/>
<person name="Wei Y."/>
<person name="Garrett M.D."/>
<person name="Nelson D."/>
<person name="Adams P.D."/>
<person name="Wang J."/>
<person name="Qin J."/>
<person name="Chow L.T."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="10995387"/>
<dbReference type="DOI" id="10.1101/gad.829500"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH CCNA1; CCNE1 AND CDK2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-775; SER-779; SER-1100; THR-1270 AND THR-1350 BY CDK2</scope>
<scope>MUTAGENESIS OF SER-775; SER-779; SER-1100; THR-1270 AND THR-1350</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="3864" last="3871">
<title>Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line.</title>
<authorList>
<person name="Kim W.-J."/>
<person name="Vo Q.N."/>
<person name="Shrivastav M."/>
<person name="Lataxes T.A."/>
<person name="Brown K.D."/>
</authorList>
<dbReference type="PubMed" id="12032824"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205485"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Cell" volume="114" first="255" last="266">
<title>S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component.</title>
<authorList>
<person name="Zheng L."/>
<person name="Roeder R.G."/>
<person name="Luo Y."/>
</authorList>
<dbReference type="PubMed" id="12887926"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00552-x"/>
</citation>
<scope>INTERACTION WITH GAPDH; NME1; NME2 AND STIP1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="2821" last="2833">
<title>NPAT expression is regulated by E2F and is essential for cell cycle progression.</title>
<authorList>
<person name="Gao G."/>
<person name="Bracken A.P."/>
<person name="Burkard K."/>
<person name="Pasini D."/>
<person name="Classon M."/>
<person name="Attwooll C."/>
<person name="Sagara M."/>
<person name="Imai T."/>
<person name="Helin K."/>
<person name="Zhao J."/>
</authorList>
<dbReference type="PubMed" id="12665581"/>
<dbReference type="DOI" id="10.1128/mcb.23.8.2821-2833.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="3669" last="3680">
<title>The cyclin E/Cdk2 substrate and Cajal body component p220(NPAT) activates histone transcription through a novel LisH-like domain.</title>
<authorList>
<person name="Wei Y."/>
<person name="Jin J."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="12724424"/>
<dbReference type="DOI" id="10.1128/mcb.23.10.3669-3680.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF VAL-7; LEU-10; VAL-11; LEU-15; GLU-18; PHE-27 AND GLU-30</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="8110" last="8123">
<title>Identification of HiNF-P, a key activator of cell cycle-controlled histone H4 genes at the onset of S phase.</title>
<authorList>
<person name="Mitra P."/>
<person name="Xie R.-L."/>
<person name="Medina R."/>
<person name="Hovhannisyan H."/>
<person name="Zaidi S.K."/>
<person name="Wei Y."/>
<person name="Harper J.W."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="14585971"/>
<dbReference type="DOI" id="10.1128/mcb.23.22.8110-8123.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-775; SER-779; SER-1100; THR-1270 AND THR-1350</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="8586" last="8600">
<title>The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and Cajal body maintenance in human somatic cells.</title>
<authorList>
<person name="Ye X."/>
<person name="Wei Y."/>
<person name="Nalepa G."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="14612403"/>
<dbReference type="DOI" id="10.1128/mcb.23.23.8586-8600.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="325" first="1509" last="1516">
<title>Dynamic interaction of p220(NPAT) and CBP/p300 promotes S-phase entry.</title>
<authorList>
<person name="Wang A."/>
<person name="Ikura T."/>
<person name="Eto K."/>
<person name="Ota M.S."/>
</authorList>
<dbReference type="PubMed" id="15555599"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.10.198"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCNE1 AND CREBBP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-775; SER-779; SER-1100; THR-1270 AND THR-1350</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="1133" last="1143">
<title>DNA damage induces downregulation of histone gene expression through the G1 checkpoint pathway.</title>
<authorList>
<person name="Su C."/>
<person name="Gao G."/>
<person name="Schneider S."/>
<person name="Helt C."/>
<person name="Weiss C."/>
<person name="O'Reilly M.A."/>
<person name="Bohmann D."/>
<person name="Zhao J."/>
</authorList>
<dbReference type="PubMed" id="14976556"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600120"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37400" last="37407">
<title>Coordinate control and selective expression of the full complement of replication-dependent histone H4 genes in normal and cancer cells.</title>
<authorList>
<person name="Holmes W.F."/>
<person name="Braastad C.D."/>
<person name="Mitra P."/>
<person name="Hampe C."/>
<person name="Doenecke D."/>
<person name="Albig W."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="16131487"/>
<dbReference type="DOI" id="10.1074/jbc.m506995200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="6140" last="6153">
<title>HiNF-P directly links the cyclin E/CDK2/p220NPAT pathway to histone H4 gene regulation at the G1/S phase cell cycle transition.</title>
<authorList>
<person name="Miele A."/>
<person name="Braastad C.D."/>
<person name="Holmes W.F."/>
<person name="Mitra P."/>
<person name="Medina R."/>
<person name="Xie R.-L."/>
<person name="Zaidi S.K."/>
<person name="Ye X."/>
<person name="Wei Y."/>
<person name="Harper J.W."/>
<person name="van Wijnen A.J."/>
<person name="Stein J.L."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="15988025"/>
<dbReference type="DOI" id="10.1128/mcb.25.14.6140-6153.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MIZF</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="40330" last="40340">
<title>Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression.</title>
<authorList>
<person name="Gangwani L."/>
</authorList>
<dbReference type="PubMed" id="17068332"/>
<dbReference type="DOI" id="10.1074/jbc.m608165200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="J. Cell. Physiol." volume="209" first="883" last="893">
<title>Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase.</title>
<authorList>
<person name="Becker K.A."/>
<person name="Ghule P.N."/>
<person name="Therrien J.A."/>
<person name="Lian J.B."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="16972248"/>
<dbReference type="DOI" id="10.1002/jcp.20776"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="14808" last="14812">
<title>FLASH is required for histone transcription and S-phase progression.</title>
<authorList>
<person name="Barcaroli D."/>
<person name="Bongiorno-Borbone L."/>
<person name="Terrinoni A."/>
<person name="Hofmann T.G."/>
<person name="Rossi M."/>
<person name="Knight R.A."/>
<person name="Matera A.G."/>
<person name="Melino G."/>
<person name="De Laurenzi V."/>
</authorList>
<dbReference type="PubMed" id="17003125"/>
<dbReference type="DOI" id="10.1073/pnas.0604227103"/>
</citation>
<scope>INTERACTION WITH CASP8AP2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="10334" last="10342">
<title>The HiNF-P/p220NPAT cell cycle signaling pathway controls nonhistone target genes.</title>
<authorList>
<person name="Medina R."/>
<person name="van der Deen M."/>
<person name="Miele-Chamberland A."/>
<person name="Xie R.-L."/>
<person name="van Wijnen A.J."/>
<person name="Stein J.L."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="17974976"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-1560"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Gene" volume="402" first="94" last="102">
<title>Transcriptional activation of the histone nuclear factor P (HiNF-P) gene by HiNF-P and its cyclin E/CDK2 responsive co-factor p220NPAT defines a novel autoregulatory loop at the G1/S phase transition.</title>
<authorList>
<person name="Xie R.-L."/>
<person name="Liu L."/>
<person name="Mitra P."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="17826007"/>
<dbReference type="DOI" id="10.1016/j.gene.2007.07.027"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="101" first="181" last="191">
<title>HiNF-P is a bifunctional regulator of cell cycle controlled histone H4 gene transcription.</title>
<authorList>
<person name="Mitra P."/>
<person name="Xie R.-L."/>
<person name="Harper J.W."/>
<person name="Stein J.L."/>
<person name="Stein G.S."/>
<person name="van Wijnen A.J."/>
</authorList>
<dbReference type="PubMed" id="17163457"/>
<dbReference type="DOI" id="10.1002/jcb.21157"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-775; SER-779; SER-1100; THR-1270 AND THR-1350</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="210" first="517" last="526">
<title>Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells.</title>
<authorList>
<person name="Becker K.A."/>
<person name="Stein J.L."/>
<person name="Lian J.B."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="17096384"/>
<dbReference type="DOI" id="10.1002/jcp.20903"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="213" first="9" last="17">
<title>Cell cycle dependent phosphorylation and subnuclear organization of the histone gene regulator p220(NPAT) in human embryonic stem cells.</title>
<authorList>
<person name="Ghule P.N."/>
<person name="Becker K.A."/>
<person name="Harper J.W."/>
<person name="Lian J.B."/>
<person name="Stein J.L."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="17520687"/>
<dbReference type="DOI" id="10.1002/jcp.21119"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="435" last="447">
<title>Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition.</title>
<authorList>
<person name="DeRan M."/>
<person name="Pulvino M."/>
<person name="Greene E."/>
<person name="Su C."/>
<person name="Zhao J."/>
</authorList>
<dbReference type="PubMed" id="17967892"/>
<dbReference type="DOI" id="10.1128/mcb.00607-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BZW1; RUVBL1; RUVBL2; TRRAP AND YY1</scope>
<scope>MUTAGENESIS OF 331-LEU--ASP-333</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1228</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-554; SER-1151; SER-1200 AND THR-1350</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1116; LYS-1149 AND LYS-1280</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="6 7 8 9 11 12 16 17 18 21 22 23 24 28">Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters.</text>
</comment>
<comment type="subunit">
<text evidence="7 10 16 17 19 23 28">Interacts with the cylin/CDK complexes CCNE1/CDK2 and CCNA1/CDK2. Interacts with BZW1, CASP8AP2, CREBBP, MIZF and YY1. Interacts with the RUVBL1, RUVBL2 and TRRAP subunits of the NuA4 complex. May also interact with GAPDH, NME1, NME2 and STIP1.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Cajal body</location>
</subcellularLocation>
<text>Concentrates in two Cajal bodies tethered to histone gene clusters at chromosome 6p21 during G1, S and G2 phases. Also concentrates in two additional Cajal bodies tethered to histone gene clusters at chromosome 1q21 specifically during S and G2 phases.</text>
</comment>
<comment type="tissue specificity">
<text evidence="25 26">Ubiquitously expressed.</text>
</comment>
<comment type="developmental stage">
<text evidence="20 28">Expressed throughout the cell cycle. Expression peaks at the G1/S phase boundary and declines during S phase.</text>
</comment>
<comment type="induction">
<text evidence="8 20">By expression of E2F1, E2F2, E2F3 and E2F4. Expression is reduced in response to radiation-induced DNA damage.</text>
</comment>
<comment type="domain">
<text evidence="9">The LisH domain is required for the activation of histone gene transcription.</text>
</comment>
<comment type="PTM">
<text evidence="7 14 28">Phosphorylated at Ser-775, Ser-779, Ser-1100, Thr-1270 and Thr-1350 by CCNE1/CDK2 at G1-S transition and until prophase, which promotes association with histone gene clusters and stimulates activation of histone transcription. Also phosphorylated by CCNA1/CDK2 in vitro.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the NPAT family.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAB02735" version="1"/>
</conflict>
<text>Chimeric cDNA. A chimeric cDNA originating from chromosomes 11 and 4.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH40356" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH50561" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<dbReference type="EMBL" id="D83243">
<property type="protein sequence ID" value="BAA11861.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X97186">
<property type="protein sequence ID" value="CAA65824.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D89854">
<property type="protein sequence ID" value="BAA21367.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290020">
<property type="protein sequence ID" value="BAF82709.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291687">
<property type="protein sequence ID" value="BAF84376.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040356">
<property type="protein sequence ID" value="AAH40356.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC050561">
<property type="protein sequence ID" value="AAH50561.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U58852">
<property type="protein sequence ID" value="AAB02735.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS41710.1"/>
<dbReference type="RefSeq" id="NP_002510.2">
<property type="nucleotide sequence ID" value="NM_002519.2"/>
</dbReference>
<dbReference type="SMR" id="Q14207"/>
<dbReference type="BioGRID" id="110924">
<property type="interactions" value="34"/>
</dbReference>
<dbReference type="DIP" id="DIP-59961N"/>
<dbReference type="ELM" id="Q14207"/>
<dbReference type="IntAct" id="Q14207">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000278612"/>
<dbReference type="iPTMnet" id="Q14207"/>
<dbReference type="PhosphoSitePlus" id="Q14207"/>
<dbReference type="BioMuta" id="NPAT"/>
<dbReference type="DMDM" id="296439285"/>
<dbReference type="EPD" id="Q14207"/>
<dbReference type="jPOST" id="Q14207"/>
<dbReference type="MassIVE" id="Q14207"/>
<dbReference type="MaxQB" id="Q14207"/>
<dbReference type="PaxDb" id="Q14207"/>
<dbReference type="PeptideAtlas" id="Q14207"/>
<dbReference type="PRIDE" id="Q14207"/>
<dbReference type="ProteomicsDB" id="59930"/>
<dbReference type="Antibodypedia" id="45544">
<property type="antibodies" value="37 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000278612">
<property type="protein sequence ID" value="ENSP00000278612"/>
<property type="gene ID" value="ENSG00000149308"/>
</dbReference>
<dbReference type="GeneID" id="4863"/>
<dbReference type="KEGG" id="hsa:4863"/>
<dbReference type="UCSC" id="uc001pjz.6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4863"/>
<dbReference type="DisGeNET" id="4863"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000149308.16"/>
<dbReference type="GeneCards" id="NPAT"/>
<dbReference type="HGNC" id="HGNC:7896">
<property type="gene designation" value="NPAT"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000149308">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601448">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14207"/>
<dbReference type="OpenTargets" id="ENSG00000149308"/>
<dbReference type="PharmGKB" id="PA31697"/>
<dbReference type="eggNOG" id="ENOG502QYUR">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000012388"/>
<dbReference type="HOGENOM" id="CLU_004845_0_0_1"/>
<dbReference type="InParanoid" id="Q14207"/>
<dbReference type="OMA" id="NFHGSKS"/>
<dbReference type="OrthoDB" id="80675at2759"/>
<dbReference type="PhylomeDB" id="Q14207"/>
<dbReference type="TreeFam" id="TF332825"/>
<dbReference type="PathwayCommons" id="Q14207"/>
<dbReference type="SIGNOR" id="Q14207"/>
<dbReference type="BioGRID-ORCS" id="4863">
<property type="hits" value="689 hits in 880 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NPAT">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="NPAT_(gene)"/>
<dbReference type="GenomeRNAi" id="4863"/>
<dbReference type="Pharos" id="Q14207">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14207"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q14207">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000149308">
<property type="expression patterns" value="Expressed in secondary oocyte and 230 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14207">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14207">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015030">
<property type="term" value="C:Cajal body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097504">
<property type="term" value="C:Gemini of coiled bodies"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000083">
<property type="term" value="P:regulation of transcription involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR006594">
<property type="entry name" value="LisH"/>
</dbReference>
<dbReference type="InterPro" id="IPR031442">
<property type="entry name" value="NPAT_C"/>
</dbReference>
<dbReference type="Pfam" id="PF15712">
<property type="entry name" value="NPAT_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00667">
<property type="entry name" value="LisH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50896">
<property type="entry name" value="LISH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Protein NPAT" id="PRO_0000318163">
<location>
<begin position="1"/>
<end position="1427"/>
</location>
</feature>
<feature type="domain" description="LisH" evidence="5">
<location>
<begin position="3"/>
<end position="35"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MIZF" evidence="17">
<location>
<begin position="1"/>
<end position="318"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of histone gene transcription and interaction with MIZF" evidence="17">
<location>
<begin position="5"/>
<end position="25"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of histone gene transcription and interaction with MIZF" evidence="17">
<location>
<begin position="121"/>
<end position="145"/>
</location>
</feature>
<feature type="region of interest" description="Mediates transcriptional activation">
<location>
<begin position="262"/>
<end position="338"/>
</location>
</feature>
<feature type="region of interest" description="Required for acceleration of G1 phase">
<location>
<begin position="629"/>
<end position="653"/>
</location>
</feature>
<feature type="region of interest" description="Required for acceleration of G1 phase">
<location>
<begin position="828"/>
<end position="853"/>
</location>
</feature>
<feature type="region of interest" description="Required for acceleration of G1 phase">
<location>
<begin position="1039"/>
<end position="1054"/>
</location>
</feature>
<feature type="region of interest" description="Required for acceleration of G1 phase">
<location>
<begin position="1228"/>
<end position="1252"/>
</location>
</feature>
<feature type="region of interest" description="Required for acceleration of G1 phase">
<location>
<begin position="1325"/>
<end position="1349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="599"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="7">
<location>
<position position="775"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="7">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="7">
<location>
<position position="1100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1151"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1200"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="1">
<location>
<position position="1228"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1254"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK2" evidence="7">
<location>
<position position="1270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK2" evidence="2 7">
<location>
<position position="1350"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="3">
<location>
<position position="1116"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="3">
<location>
<position position="1149"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="3">
<location>
<position position="1280"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1131748." id="VAR_038696" evidence="26">
<original>I</original>
<variation>L</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051521." id="VAR_038697" evidence="26">
<original>L</original>
<variation>M</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35504388." id="VAR_038698">
<original>V</original>
<variation>M</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs968207." id="VAR_038699">
<original>I</original>
<variation>L</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4144901." id="VAR_038700" evidence="13">
<original>L</original>
<variation>F</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2070661." id="VAR_038701" evidence="13 15 25 26 27">
<original>V</original>
<variation>I</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35095430." id="VAR_038702">
<original>V</original>
<variation>A</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051522." id="VAR_038703" evidence="26">
<original>V</original>
<variation>I</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1131750." id="VAR_038704" evidence="26">
<original>Q</original>
<variation>E</variation>
<location>
<position position="967"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1131751." id="VAR_038705" evidence="26">
<original>L</original>
<variation>V</variation>
<location>
<position position="973"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051524." id="VAR_038706" evidence="26">
<original>V</original>
<variation>A</variation>
<location>
<position position="987"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34052882." id="VAR_038707" evidence="13">
<original>N</original>
<variation>K</variation>
<location>
<position position="999"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051525." id="VAR_038708" evidence="26">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-10; A-11; A-15 and A-18." evidence="9">
<original>V</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-7; A-11; A-15 and A-18." evidence="9">
<original>L</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-7; A-10; A-15 and A-18." evidence="9">
<original>V</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-7; A-10; A-11 and A-18." evidence="9">
<original>L</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-7; A-10; A-11 and A-15." evidence="9">
<original>E</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-30." evidence="9">
<original>F</original>
<variation>A</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-27." evidence="9">
<original>E</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription. Impairs interaction with BZW1, RUVBL1, RUVBL2 and TRRAP." evidence="23">
<original>LFD</original>
<variation>AAA</variation>
<location>
<begin position="331"/>
<end position="333"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-779; A-1100; A-1270 and A-1350." evidence="7 11 16 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="775"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-775; A-1100; A-1270 and A-1350." evidence="7 11 16 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-775; A-779; A-1270 and A-1350." evidence="7 11 16 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="1100"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-775; A-779; A-1100 and A-1350." evidence="7 11 16 21">
<original>T</original>
<variation>A</variation>
<location>
<position position="1270"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs activation of histone gene transcription; when associated with A-775; A-779; A-1100 and A-1270." evidence="7 11 16 21">
<original>T</original>
<variation>A</variation>
<location>
<position position="1350"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB02735." ref="6" evidence="29">
<original>S</original>
<variation>Y</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF84376." ref="4" evidence="29">
<original>S</original>
<variation>N</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF84376." ref="4" evidence="29">
<original>F</original>
<variation>L</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA65824." ref="2" evidence="29">
<original>Y</original>
<variation>N</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF82709." ref="4" evidence="29">
<original>E</original>
<variation>G</variation>
<location>
<position position="785"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF82709." ref="4" evidence="29">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1145"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BMA5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00126"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10995386"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10995387"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12665581"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12724424"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12887926"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14585971"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14612403"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14976556"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15555599"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15988025"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16131487"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17003125"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17096384"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17163457"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17826007"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17967892"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974976"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8743993"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8923007"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9205109"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9472014"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="1427" mass="154290" checksum="D5C5E630A56227F9" modified="2010-05-18" version="3">MLLPSDVARLVLGYLQQENLISTCQTFILESSDLKEYAEHCTDEGFIPACLLSLFGKNLTTILNEYVAMKTKETSNNVPAIMSSLWKKLDHTLSQIRSMQSSPRFAGSQRARTRTGIAEIKRQRKLASQTAPASAELLTLPYLSGQFTTPPSTGTQVTRPSGQISDPSRSYFVVVNHSQSQDTVTTGEALNVIPGAQEKKAHASLMSPGRRKSESQRKSTTLSGPHSTIRNFQDPNAFAVEKQMVIENAREKILSNKSLQEKLAENINKFLTSDNNIAQVPKQTDNNPTEPETSIDEFLGLPSEIHMSEEAIQDILEQTESDPAFQALFDLFDYGKTKNNKNISQSISSQPMESNPSIVLADETNLAVKGSFETEESDGQSGQPAFCTSYQNDDPLNALKNSNNHDVLRQEDQENFSQISTSIQKKAFKTAVPTEQKCDIDITFESVPNLNDFNQRGNSNAECNPHCAELYTNQMSTETEMAIGIEKNSLSSNVPSESQLQPDQPDIPITSFVSLGCEANNENLILSGKSSQLLSQDTSLTGKPSKKSQFCENSNDTVKLKINFHGSKSSDSSEVHKSKIEINVLEPVMSQLSNCQDNSCLQSEILPVSVESSHLNVSGQVEIHLGDSLSSTKQPSNDSASVELNHTENEAQASKSENSQEPSSSVKEENTIFLSLGGNANCEKVALTPPEGTPVENSHSLPPESVCSSVGDSHPESQNTDDKPSSNNSAEIDASNIVSLKVIISDDPFVSSDTELTSAVSSINGENLPTIILSSPTKSPTKNAELVKCLSSEETVGAVVYAEVGDSASMEQSLLTFKSEDSAVNNTQNEDGIAFSANVTPCVSKDGGYIQLMPATSTAFGNSNNILIATCVTDPTALGTSVSQSNVVVLPGNSAPMTAQPLPPQLQTPPRSNSVFAVNQAVSPNFSQGSAIIIASPVQPVLQGMVGMIPVSVVGQNGNNFSTPPRQVLHMPLTAPVCNRSIPQFPVPPKSQKAQGLRNKPCIGKQVNNLVDSSGHSVGCHAQKTEVSDKSIATDLGKKSEETTVPFPEESIVPAAKPCHRRVLCFDSTTAPVANTQGPNHKMVSQNKERNAVSFPNLDSPNVSSTLKPPSNNAIKREKEKPPLPKILSKSESAISRHTTIRETQSEKKVSPTEIVLESFHKATANKENELCSDVERQKNPENSKLSIGQQNGGLRSEKSIASLQEMTKKQGTSSNNKNVLSVGTAVKDLKQEQTKSASSLITTEMLQDIQRHSSVSRLADSSDLPVPRTPGSGAGEKHKEEPIDIIKAPSSRRFSEDSSTSKVMVPPVTPDLPACSPASETGSENSVNMAAHTLMILSRAAISRTTSATPLKDNTQQFRASSRSTTKKRKIEELDERERNSRPSSKNLTNSSIPMKKKKIKKKKLPSSFPAGMDVDKFLLSLHYDE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

